 Martin Voskuil
Concepts (262)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Mycobacterium tuberculosis | 41 | 2023 | 271 | 6.990 |
Why?
| | Bacterial Proteins | 28 | 2021 | 739 | 3.580 |
Why?
| | Gene Expression Regulation, Bacterial | 27 | 2023 | 284 | 3.550 |
Why?
| | Tuberculosis | 14 | 2023 | 244 | 2.950 |
Why?
| | Regulon | 10 | 2020 | 33 | 2.020 |
Why?
| | Protein Kinases | 7 | 2016 | 306 | 1.670 |
Why?
| | Antitubercular Agents | 9 | 2023 | 170 | 1.500 |
Why?
| | Burkholderia pseudomallei | 5 | 2015 | 10 | 1.420 |
Why?
| | Mycobacterium | 2 | 2023 | 103 | 1.240 |
Why?
| | Bacteria, Anaerobic | 2 | 2017 | 20 | 0.970 |
Why?
| | Microbial Viability | 5 | 2021 | 79 | 0.910 |
Why?
| | RNA, Ribosomal | 2 | 2021 | 157 | 0.910 |
Why?
| | Oxygen Consumption | 3 | 2014 | 573 | 0.870 |
Why?
| | Mycobacterium abscessus | 1 | 2023 | 98 | 0.790 |
Why?
| | Anti-Bacterial Agents | 7 | 2018 | 1483 | 0.770 |
Why?
| | Hypoxia | 6 | 2016 | 937 | 0.750 |
Why?
| | Protamine Kinase | 2 | 2010 | 8 | 0.710 |
Why?
| | Anti-Infective Agents | 1 | 2023 | 225 | 0.700 |
Why?
| | RNA Precursors | 1 | 2021 | 136 | 0.700 |
Why?
| | DNA-Binding Proteins | 10 | 2019 | 1316 | 0.690 |
Why?
| | alpha-Amylases | 5 | 2002 | 16 | 0.650 |
Why?
| | Mycobacterium Infections, Nontuberculous | 1 | 2023 | 337 | 0.630 |
Why?
| | Adaptation, Physiological | 5 | 2023 | 476 | 0.580 |
Why?
| | Tuberculosis, Pulmonary | 5 | 2021 | 112 | 0.570 |
Why?
| | Bacillus subtilis | 5 | 1998 | 61 | 0.550 |
Why?
| | In Vitro Techniques | 4 | 2015 | 1044 | 0.540 |
Why?
| | Cell Death | 1 | 2017 | 326 | 0.530 |
Why?
| | Melioidosis | 2 | 2015 | 4 | 0.530 |
Why?
| | Anaerobiosis | 7 | 2015 | 49 | 0.510 |
Why?
| | Mycobacterium bovis | 2 | 2020 | 11 | 0.490 |
Why?
| | Stomach | 1 | 2015 | 101 | 0.480 |
Why?
| | Cell Membrane | 1 | 2018 | 683 | 0.480 |
Why?
| | Genes, Bacterial | 8 | 2016 | 156 | 0.460 |
Why?
| | Acyl-CoA Dehydrogenase | 1 | 2013 | 8 | 0.450 |
Why?
| | RNA, Bacterial | 5 | 2021 | 173 | 0.450 |
Why?
| | Promoter Regions, Genetic | 6 | 2012 | 1122 | 0.440 |
Why?
| | Nitric Oxide | 5 | 2014 | 832 | 0.440 |
Why?
| | Energy Metabolism | 1 | 2018 | 715 | 0.440 |
Why?
| | Plasma Gases | 1 | 2013 | 5 | 0.440 |
Why?
| | Chemical Phenomena | 1 | 2013 | 81 | 0.430 |
Why?
| | BCG Vaccine | 3 | 2020 | 18 | 0.430 |
Why?
| | Drug Resistance, Bacterial | 2 | 2015 | 156 | 0.430 |
Why?
| | Disinfectants | 1 | 2013 | 34 | 0.420 |
Why?
| | Hydroxyl Radical | 1 | 2013 | 89 | 0.410 |
Why?
| | Burkholderia mallei | 2 | 2008 | 7 | 0.400 |
Why?
| | Homeostasis | 3 | 2017 | 577 | 0.400 |
Why?
| | Cholesterol | 1 | 2013 | 369 | 0.390 |
Why?
| | Ceftazidime | 1 | 2011 | 5 | 0.390 |
Why?
| | Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 2011 | 39 | 0.380 |
Why?
| | Antigens, Bacterial | 4 | 2009 | 112 | 0.370 |
Why?
| | Transcription, Genetic | 12 | 2023 | 1310 | 0.370 |
Why?
| | Sigma Factor | 4 | 2021 | 33 | 0.360 |
Why?
| | Sputum | 4 | 2021 | 290 | 0.340 |
Why?
| | Mice, Inbred BALB C | 6 | 2022 | 1168 | 0.320 |
Why?
| | Genetic Techniques | 1 | 2008 | 57 | 0.310 |
Why?
| | Anion Transport Proteins | 1 | 2008 | 8 | 0.310 |
Why?
| | Disease Models, Animal | 8 | 2023 | 3580 | 0.300 |
Why?
| | Microbial Sensitivity Tests | 5 | 2023 | 299 | 0.290 |
Why?
| | Bacteria | 1 | 2013 | 729 | 0.280 |
Why?
| | Mice | 18 | 2023 | 15052 | 0.270 |
Why?
| | Stress, Physiological | 1 | 2009 | 399 | 0.260 |
Why?
| | Alleles | 1 | 2008 | 794 | 0.260 |
Why?
| | DNA, Bacterial | 5 | 2004 | 309 | 0.260 |
Why?
| | Mutation | 7 | 2021 | 3364 | 0.260 |
Why?
| | Virulence | 7 | 2021 | 231 | 0.250 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2017 | 515 | 0.250 |
Why?
| | Nitric Oxide Donors | 2 | 2012 | 15 | 0.250 |
Why?
| | Electron Transport | 2 | 2017 | 112 | 0.240 |
Why?
| | Interferon-gamma | 6 | 2016 | 726 | 0.230 |
Why?
| | Adenosine Triphosphate | 2 | 2017 | 431 | 0.230 |
Why?
| | ATP-Binding Cassette Transporters | 2 | 2016 | 123 | 0.230 |
Why?
| | Mycobacterium smegmatis | 1 | 2023 | 3 | 0.230 |
Why?
| | Triazenes | 1 | 2003 | 3 | 0.230 |
Why?
| | Phosphates | 2 | 2016 | 160 | 0.230 |
Why?
| | Plasmids | 3 | 2008 | 345 | 0.220 |
Why?
| | Animals | 19 | 2023 | 32102 | 0.220 |
Why?
| | Macrophages | 7 | 2016 | 1284 | 0.210 |
Why?
| | Nitric Oxide Synthase | 1 | 2003 | 213 | 0.210 |
Why?
| | Transcription Initiation Site | 1 | 2002 | 40 | 0.210 |
Why?
| | Base Sequence | 7 | 2012 | 2114 | 0.200 |
Why?
| | Molecular Biology | 2 | 2010 | 56 | 0.200 |
Why?
| | Benchmarking | 1 | 2023 | 163 | 0.190 |
Why?
| | Sequence Deletion | 4 | 2016 | 167 | 0.190 |
Why?
| | Immunity | 1 | 2021 | 124 | 0.180 |
Why?
| | Copper | 1 | 2021 | 101 | 0.180 |
Why?
| | Gene Expression Profiling | 8 | 2023 | 1536 | 0.170 |
Why?
| | Phenotype | 5 | 2021 | 2829 | 0.160 |
Why?
| | Biofilms | 1 | 2020 | 222 | 0.150 |
Why?
| | Oligonucleotide Array Sequence Analysis | 6 | 2009 | 746 | 0.150 |
Why?
| | Bacillus | 1 | 2017 | 14 | 0.150 |
Why?
| | Cell Respiration | 1 | 2017 | 74 | 0.150 |
Why?
| | Molecular Sequence Data | 7 | 2012 | 2790 | 0.150 |
Why?
| | Granuloma | 2 | 2016 | 85 | 0.150 |
Why?
| | Proto-Oncogene Proteins c-akt | 1 | 2019 | 400 | 0.150 |
Why?
| | Hydrogen Peroxide | 3 | 2014 | 287 | 0.150 |
Why?
| | Phosphoenolpyruvate Sugar Phosphotransferase System | 1 | 1996 | 4 | 0.140 |
Why?
| | Escherichia coli | 2 | 2002 | 730 | 0.140 |
Why?
| | Humans | 19 | 2023 | 115589 | 0.130 |
Why?
| | Oxygen | 3 | 2017 | 837 | 0.130 |
Why?
| | Colony Count, Microbial | 1 | 2015 | 112 | 0.120 |
Why?
| | Nitrates | 1 | 2015 | 72 | 0.120 |
Why?
| | Color | 1 | 2015 | 75 | 0.120 |
Why?
| | Nitrites | 1 | 2015 | 76 | 0.120 |
Why?
| | Imipenem | 1 | 2014 | 16 | 0.120 |
Why?
| | Mitomycin | 1 | 2014 | 27 | 0.120 |
Why?
| | NAD | 1 | 2015 | 67 | 0.120 |
Why?
| | Operon | 2 | 2020 | 59 | 0.120 |
Why?
| | Clofazimine | 1 | 2014 | 14 | 0.120 |
Why?
| | Transcription Factors | 3 | 2019 | 1528 | 0.120 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2016 | 608 | 0.110 |
Why?
| | Salmonella typhimurium | 1 | 2014 | 161 | 0.110 |
Why?
| | Nitroimidazoles | 1 | 2011 | 6 | 0.100 |
Why?
| | Cathelicidins | 1 | 2011 | 39 | 0.090 |
Why?
| | Electrophoretic Mobility Shift Assay | 2 | 2019 | 74 | 0.090 |
Why?
| | Vitamin K 2 | 1 | 2010 | 1 | 0.090 |
Why?
| | DNA-Directed RNA Polymerases | 2 | 2002 | 52 | 0.090 |
Why?
| | Lung | 4 | 2023 | 3672 | 0.090 |
Why?
| | Cupriavidus | 1 | 2010 | 2 | 0.090 |
Why?
| | Sequence Analysis, DNA | 1 | 1993 | 732 | 0.090 |
Why?
| | Gram-Negative Bacterial Infections | 1 | 2010 | 37 | 0.090 |
Why?
| | Drug Design | 1 | 2011 | 156 | 0.090 |
Why?
| | Drug Therapy, Combination | 2 | 2023 | 962 | 0.090 |
Why?
| | Prosthesis-Related Infections | 1 | 2010 | 70 | 0.080 |
Why?
| | Polymerase Chain Reaction | 2 | 2010 | 1000 | 0.080 |
Why?
| | Heat-Shock Response | 1 | 2009 | 46 | 0.080 |
Why?
| | Mice, Inbred C3H | 2 | 2023 | 244 | 0.080 |
Why?
| | Genetic Complementation Test | 1 | 2008 | 61 | 0.080 |
Why?
| | Flagella | 1 | 2008 | 18 | 0.080 |
Why?
| | Mutagenesis, Site-Directed | 2 | 2002 | 346 | 0.080 |
Why?
| | Iron-Sulfur Proteins | 1 | 2008 | 24 | 0.080 |
Why?
| | Female | 10 | 2023 | 59913 | 0.080 |
Why?
| | Phagosomes | 2 | 2008 | 40 | 0.070 |
Why?
| | Gene Deletion | 1 | 2009 | 355 | 0.070 |
Why?
| | Genetic Vectors | 1 | 2008 | 290 | 0.070 |
Why?
| | Treatment Outcome | 1 | 2021 | 9159 | 0.070 |
Why?
| | RNA, Messenger | 3 | 2016 | 2574 | 0.070 |
Why?
| | Defibrillators, Implantable | 1 | 2010 | 285 | 0.070 |
Why?
| | Movement | 1 | 2008 | 246 | 0.070 |
Why?
| | Lipid Metabolism | 1 | 2009 | 449 | 0.070 |
Why?
| | Chromosome Mapping | 1 | 2007 | 489 | 0.070 |
Why?
| | Culture Media | 3 | 2012 | 156 | 0.070 |
Why?
| | Uganda | 2 | 2016 | 68 | 0.070 |
Why?
| | Regulatory Sequences, Nucleic Acid | 2 | 2003 | 78 | 0.060 |
Why?
| | Sequence Homology, Nucleic Acid | 2 | 2002 | 150 | 0.060 |
Why?
| | Transcriptome | 2 | 2023 | 736 | 0.060 |
Why?
| | Repressor Proteins | 2 | 1998 | 369 | 0.060 |
Why?
| | Antigenic Variation | 1 | 2004 | 9 | 0.060 |
Why?
| | Potassium Permanganate | 1 | 2002 | 3 | 0.050 |
Why?
| | DNA Footprinting | 1 | 2002 | 28 | 0.050 |
Why?
| | Mice, Inbred Strains | 1 | 2023 | 399 | 0.050 |
Why?
| | Mice, Inbred C57BL | 3 | 2023 | 4773 | 0.050 |
Why?
| | Cluster Analysis | 1 | 2004 | 465 | 0.050 |
Why?
| | HIV Infections | 1 | 2016 | 2473 | 0.050 |
Why?
| | Copper Sulfate | 1 | 2021 | 6 | 0.050 |
Why?
| | Time Factors | 2 | 2009 | 6165 | 0.050 |
Why?
| | Crystallins | 1 | 2001 | 41 | 0.050 |
Why?
| | Transcriptional Activation | 1 | 2002 | 340 | 0.050 |
Why?
| | Aconitate Hydratase | 2 | 2012 | 17 | 0.050 |
Why?
| | Consensus Sequence | 2 | 2002 | 70 | 0.040 |
Why?
| | Mice, SCID | 1 | 2021 | 321 | 0.040 |
Why?
| | Models, Genetic | 2 | 2008 | 570 | 0.040 |
Why?
| | Bacterial Adhesion | 1 | 2020 | 78 | 0.040 |
Why?
| | Biological Transport | 1 | 2021 | 375 | 0.040 |
Why?
| | Guinea Pigs | 2 | 2010 | 151 | 0.040 |
Why?
| | Threonine | 1 | 2019 | 40 | 0.040 |
Why?
| | Protein Conformation | 1 | 2002 | 822 | 0.040 |
Why?
| | Cell Wall | 2 | 2009 | 50 | 0.040 |
Why?
| | Binding Sites | 1 | 2002 | 1177 | 0.040 |
Why?
| | Oxidative Stress | 3 | 2014 | 1093 | 0.040 |
Why?
| | Lactococcus lactis | 1 | 1998 | 2 | 0.040 |
Why?
| | Lactobacillus | 1 | 1998 | 24 | 0.040 |
Why?
| | Cells, Cultured | 3 | 2014 | 3914 | 0.040 |
Why?
| | NADP | 1 | 1998 | 42 | 0.040 |
Why?
| | T-Lymphocytes | 1 | 2006 | 1756 | 0.040 |
Why?
| | Adult | 6 | 2021 | 30719 | 0.040 |
Why?
| | Gram-Positive Bacteria | 1 | 1998 | 46 | 0.040 |
Why?
| | Corynebacterium | 1 | 1998 | 36 | 0.040 |
Why?
| | Oxidation-Reduction | 2 | 2012 | 924 | 0.040 |
Why?
| | Mutagenesis | 1 | 1998 | 170 | 0.040 |
Why?
| | Amino Acid Sequence | 2 | 2012 | 2000 | 0.040 |
Why?
| | Signal Transduction | 1 | 2010 | 4541 | 0.040 |
Why?
| | Streptococcus pneumoniae | 1 | 1998 | 133 | 0.040 |
Why?
| | Enzyme Repression | 1 | 1996 | 8 | 0.040 |
Why?
| | Gambia | 1 | 2016 | 12 | 0.030 |
Why?
| | Gene Order | 1 | 2016 | 24 | 0.030 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 2 | 2012 | 930 | 0.030 |
Why?
| | Cell Line | 3 | 2009 | 2651 | 0.030 |
Why?
| | Nitrogen Oxides | 1 | 2016 | 47 | 0.030 |
Why?
| | Protein Binding | 3 | 2012 | 1917 | 0.030 |
Why?
| | Adaptation, Biological | 1 | 2016 | 54 | 0.030 |
Why?
| | Phosphorylation | 1 | 2019 | 1571 | 0.030 |
Why?
| | Specimen Handling | 1 | 2016 | 156 | 0.030 |
Why?
| | Drug Monitoring | 1 | 2016 | 184 | 0.030 |
Why?
| | Proton-Motive Force | 1 | 2014 | 6 | 0.030 |
Why?
| | Point Mutation | 1 | 1995 | 217 | 0.030 |
Why?
| | DNA Mutational Analysis | 1 | 1995 | 372 | 0.030 |
Why?
| | Bacterial Load | 1 | 2014 | 60 | 0.030 |
Why?
| | Necrosis | 1 | 2014 | 210 | 0.030 |
Why?
| | Phosphotransferases | 1 | 2012 | 25 | 0.030 |
Why?
| | Nucleotide Motifs | 1 | 2012 | 30 | 0.030 |
Why?
| | Nitroso Compounds | 1 | 2012 | 5 | 0.030 |
Why?
| | Spermine | 1 | 2012 | 27 | 0.030 |
Why?
| | Nitric Oxide Synthase Type II | 1 | 2012 | 160 | 0.030 |
Why?
| | Disulfides | 1 | 2012 | 91 | 0.030 |
Why?
| | Oxidoreductases | 1 | 2012 | 92 | 0.030 |
Why?
| | Phagocytes | 1 | 2012 | 92 | 0.030 |
Why?
| | GTP-Binding Proteins | 1 | 2012 | 142 | 0.030 |
Why?
| | Electrophoresis, Polyacrylamide Gel | 1 | 2012 | 312 | 0.030 |
Why?
| | Oxidants | 1 | 2012 | 112 | 0.030 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2012 | 352 | 0.020 |
Why?
| | Glucose | 1 | 1996 | 904 | 0.020 |
Why?
| | Cysteine | 1 | 2012 | 173 | 0.020 |
Why?
| | Biomarkers | 1 | 2021 | 3467 | 0.020 |
Why?
| | Drug Resistance, Multiple | 1 | 2011 | 19 | 0.020 |
Why?
| | Crystallography, X-Ray | 1 | 2012 | 408 | 0.020 |
Why?
| | Stereoisomerism | 1 | 2011 | 91 | 0.020 |
Why?
| | Immunity, Innate | 1 | 2016 | 731 | 0.020 |
Why?
| | Antimicrobial Cationic Peptides | 1 | 2011 | 76 | 0.020 |
Why?
| | DNA Probes | 1 | 2010 | 59 | 0.020 |
Why?
| | DNA | 2 | 2012 | 1356 | 0.020 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 1 | 2011 | 177 | 0.020 |
Why?
| | Amino Acid Substitution | 1 | 2011 | 267 | 0.020 |
Why?
| | Protein Structure, Tertiary | 1 | 2012 | 804 | 0.020 |
Why?
| | Protein Structure, Secondary | 1 | 2011 | 327 | 0.020 |
Why?
| | Hemolysis | 1 | 2011 | 146 | 0.020 |
Why?
| | Structure-Activity Relationship | 1 | 2011 | 511 | 0.020 |
Why?
| | Propionates | 1 | 2009 | 33 | 0.020 |
Why?
| | Nucleic Acid Conformation | 1 | 2012 | 672 | 0.020 |
Why?
| | In Situ Hybridization, Fluorescence | 1 | 2010 | 310 | 0.020 |
Why?
| | Microscopy, Fluorescence | 1 | 2010 | 402 | 0.020 |
Why?
| | Mice, Knockout | 1 | 2014 | 2604 | 0.020 |
Why?
| | NADPH Oxidases | 1 | 2008 | 122 | 0.020 |
Why?
| | Male | 4 | 2021 | 55949 | 0.020 |
Why?
| | Models, Molecular | 1 | 2012 | 1390 | 0.020 |
Why?
| | Gene Expression | 1 | 2012 | 1436 | 0.020 |
Why?
| | Superoxides | 1 | 2008 | 215 | 0.020 |
Why?
| | Host-Pathogen Interactions | 1 | 2009 | 296 | 0.020 |
Why?
| | Tuberculin Test | 1 | 2006 | 32 | 0.020 |
Why?
| | Lipids | 1 | 2009 | 588 | 0.020 |
Why?
| | Statistics as Topic | 1 | 2006 | 299 | 0.020 |
Why?
| | Cattle | 1 | 2007 | 935 | 0.010 |
Why?
| | Lymphocyte Activation | 1 | 2007 | 1057 | 0.010 |
Why?
| | Gene Targeting | 1 | 2003 | 75 | 0.010 |
Why?
| | Aspartic Acid | 1 | 2003 | 79 | 0.010 |
Why?
| | Diamide | 1 | 2002 | 4 | 0.010 |
Why?
| | Sulfhydryl Reagents | 1 | 2002 | 11 | 0.010 |
Why?
| | Species Specificity | 1 | 2004 | 552 | 0.010 |
Why?
| | Genes, Reporter | 1 | 2003 | 257 | 0.010 |
Why?
| | Logistic Models | 1 | 2007 | 1856 | 0.010 |
Why?
| | Sequence Alignment | 1 | 2002 | 327 | 0.010 |
Why?
| | Aerobiosis | 1 | 2001 | 20 | 0.010 |
Why?
| | Models, Biological | 1 | 2008 | 1646 | 0.010 |
Why?
| | Hot Temperature | 1 | 2002 | 303 | 0.010 |
Why?
| | Cell Proliferation | 1 | 2006 | 2194 | 0.010 |
Why?
| | Vaccination | 1 | 2007 | 1209 | 0.010 |
Why?
| | Adolescent | 2 | 2007 | 17890 | 0.010 |
Why?
| | Kinetics | 1 | 2001 | 1569 | 0.010 |
Why?
| | Middle Aged | 2 | 2007 | 26998 | 0.010 |
Why?
| | Reproducibility of Results | 1 | 2004 | 2800 | 0.010 |
Why?
| | Child, Preschool | 1 | 2006 | 9133 | 0.010 |
Why?
| | Aged | 1 | 2006 | 19250 | 0.000 |
Why?
| | Child | 1 | 2006 | 18489 | 0.000 |
Why?
|
|
Voskuil's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|